Data Scientist

We are seeking a highly motivated Data Scientist with strong software engineering skills to join the Biometrics and Data Management group. This role will focus on advancing the current platform and developing novel and scalable data science tools to support evolving business needs. As a key contributor in a multidisciplinary environment, you will work closely with clinical scientists, biostatisticians, data managers, statistical programmers, and other stakeholders to design, implement and deploy robust data-driven solutions that accelerate decision-making and improve patient outcomes. In addition to modeling and analytics work, you will contribute to building production-grade tools and frameworks that extend the capabilities of the current internal platforms., * Enhance the existing platforms by contributing to the development, validation, deployment, and ongoing maintenance.

• Develop and validate data science tools for clinical research, and trial optimization.
• Ensure the scalability, maintainability, and reliability of analytical solutions through software engineering best practices (e.g., testing, documentation, CI/CD pipeline).

• Bachelor's degree in computer science, Data Science, Statistics, Mathematics, or a related field.
• Minimum of 10 years of Data Science experience with a Bachelor's degree, 8 years with a Master's, or 4 years with a Ph.D., including at least 3 years of hands-on experience developing production-grade software in programming languages such as Python or R.
• Demonstrated understanding of software architecture, performance optimization and validation.
• Strong expertise in Machine Learning and Deep Learning techniques (e.g., Scikit-learn, TensorFlow, or PyTorch).
• Familiar with data visualization tools such as ggplot2. Plotly, Matplotlib or Seaborn.
• Strong analytical thinking and problem-solving skills.
• Experienced with Github., * Master's or Ph.D degree in Computer Science, Machine Learning, Statistics, Mathematics, or a related field.
• Experience with cloud-computing platforms (AWS, GCP, or Azure) and containerization (e.g., Docker).
• Experience with creating Large Language Models (LLMs) and GenAI based solution in production environment.
• Experienced in designing and implementing CI/CD pipelines.

Structure Therapeutics is committed to fair and equitable compensation practices, and we strive to provide employees with total compensation packages that are market competitive. For this role, the anticipated base pay range is $148K-$182K. The exact base pay offered for this role will depend on various factors, including but not limited to the candidate's geography, qualifications, skills, and experience.

At Structure, base pay is only one part of your total compensation package. The successful candidate will be eligible for an annual performance incentive bonus, new hire equity, and ongoing performance-based equity. Structure Therapeutics also offers various benefits offerings, including, but not limited to, medical, dental, and vision insurance, 401k match, unlimited PTO, and a number of paid holidays including winter shutdown.

Notice to Recruiters/Staffing Agencies

Recruiters and staffing agencies should not contact Structure Therapeutics through this page. All recruitment vendors (search firms, recruitment agencies, and staffing companies) are prohibited from contacting our hiring manager(s), executive team members, or employees.

We require that all recruiters and staffing agencies have a fully executed, formal written agreement on file.

Structure Therapeutics develops life-changing medicines for patients using advanced structure-based and computational drug discovery technology. The company's platform combines the latest advancements in visualization of molecular interactions, computational chemistry, and data integration to design orally available, superior small molecule medicines that overcome current limitations of biologic and peptide drugs. We are advancing a clinical-stage pipeline of differentiated treatments focused on chronic diseases with high unmet need, including cardiovascular, metabolic, and pulmonary conditions. Structure Therapeutics is led by an experienced group of international drug innovators and financed by top-tier global life sciences investors. The company completed an initial public offering (IPO) in February 2023. With offices in California and Shanghai, Structure Therapeutics has the benefit of being at the center of life science innovation in both the US and China and capitalizing on the strengths of each geographic location.